Ma, Ji <br/><br/>
C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision.  [electronic resource] 

 -  Science China. Life sciences  Sep 2019 
 - 1229-1242 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1869-1889 
<br/><br/><label>Standard No.: </label>10.1007/s11427-019-9570-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--genetics<br/>Carcinogenesis--genetics<br/>Carrier Proteins--genetics<br/>Cell Differentiation<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cell Transformation, Neoplastic--genetics<br/>DNA-Binding Proteins--genetics<br/>Databases, Nucleic Acid<br/>Female<br/>GATA3 Transcription Factor--genetics<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunity, Innate--genetics<br/>Neoplasms, Basal Cell--genetics<br/>Transcription Factors--genetics